Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS
· Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Feb 5, 2025
Nika Pharmaceuticals Company Description
Nika Pharmaceuticals, Inc. engages in the development and distribution of various pharmaceutical products.
It develops dietary supplements and antiviral drugs; and thymus nuclear glycoprotein (TNG) for the treatment of HIV.
The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022.
Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Nika Pharmaceuticals, Inc.
| Country | United States |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Dimitar Savov |
Contact Details
Address: 2269 Merrimack Valley Avenue Henderson, Colorado 89044 United States | |
| Phone | 702 326 3615 |
| Website | nikapharmaceuticals.com |
Stock Details
| Ticker Symbol | NIKA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US46020A1060 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dimitar Slavchev Savov | President, Chief Executive Officer, Chief Financial Officer and Director |
| Clifford Redekop | Secretary and Director |
| Dr. Darena Zlateva | Chief Scientific Officer |